Skip to content
    Vensana Capital logo

    Vensana Capital

    Minneapolis, Minnesota, United StatesFounded 2019

    Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare through breakthrough innovations in medical technology. The firm invests in development- and commercial-stage medtech companies, with offices in Minneapolis, MN and McLean, VA.

    62% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 5 prior). Average disclosed round size is $57.6M (across 22 rounds with reported amounts).

    Find people at Vensana Capital on Goldilocks AI

    Portfolio

    21

    Fund Size

    $425M

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    JK

    Justin Klein, MD, JD

    Co-founder and Managing Partner

    KN

    Kirk Nielsen

    co-founder and Managing Partner

    AS

    Amrinder Singh

    Partner

    BH

    Bill Hoffman

    Venture Partner

    GB

    Greg Banker

    Partner

    MB

    Maria Berkman, MD

    Partner

    MK

    Mike Kramer

    Partner

    SS

    Steve Schwen

    Partner and Chief Financial Officer

    TT

    Thomas Tu, MD

    Venture Partner

    AK

    Allison King

    Investment Professional

    PG

    Petra Gorombei, PhD

    Investment Professional

    EE

    Elise Erkens

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    24 investments
    CompanyRoundAmountDate
    Ventaris Surgical logoVentaris SurgicalSeries A$30MJan 2026
    ForSight Robotics logoForSight RoboticsSeries B$125MJun 2025
    SSpyGlass Pharma, IncSeries D—Jun 2025
    Spyglass logoSpyglassSeries D$75MJun 2025
    Cleerly logoCleerlySeries C$106MDec 2024
    Okami Medical logoOkami MedicalUnknown$32.5MOct 2024
    Spyglass logoSpyglassSeries C$90MJul 2023
    Relievant MedSystems logoRelievant MedSystemsSeries G$50MApr 2023
    Volta Medical logoVolta MedicalSeries B—Jan 2023
    Nyra Medical, Inc. logoNyra Medical, Inc.Series A$20MNov 2022
    Cleerly logoCleerlySeries C$106MJan 2022
    Apella Technology logoApella TechnologySeries A$21MDec 2021
    CCleerly CoronarySeries B$43MJun 2021
    Spyglass logoSpyglassSeries B$27.5MJan 2021
    PPersonal Genome Diagnostics (PGDx)Series C$103MJan 2021
    Relievant MedSystems logoRelievant MedSystemsSeries D$70MOct 2020
    CVRx logoCVRxUnknown$50MJul 2020
    PGDx logoPGDxSeries C$103MJan 2014
    AAlleviant Medical, Inc.Unknown$75M—
    VVesper Medical IncUnknown$37M—
    LLuna HealthSeries A$23.6M—
    Artelon logoArtelonSeries B$20M—
    Moxe logoMoxeSeries B$30M—
    TYBR Health logoTYBR HealthSeries A$30M—

    Top Co-Investors

    Last updated: 7 October 2026